EML4 and lung carcinoma: These cell lines were derived from the parental H3122 cells (Lovly et al, 2011) and STE‐1 cells, a patient‐derived lung cancer cell line described in (Lovly et al, 2014), both of which carry the EML4‐ALK (E13;A20) translocation.